Patient experience evaluation of the CMO-based pharmaceutical care model vs usual care in people living with HIV

…, P Diaz-Ruiz, E Molina-Cuadrado… - Journal of …, 2022 - Taylor & Francis
Objective To compare patient experience in a real-life population of people living with HIV
(PLWH) who received pharmaceutical care (PC) based on the Capacity-Motivation …

Long-term cost-effectiveness of ticagrelor versus clopidogrel in acute coronary syndrome in Spain

E Molina-Cuadrado, H Mateo-Carrasco… - … : organo oficial de …, 2014 - europepmc.org
Objective To assess the cost-effectiveness relationship of Ticagrelor versus Clopidogrel for
the management of acute coronary syndrome in Spain. Methods The data from the PLATO …

Role of high-dose levetiracetam as add-on therapy for intractable epilepsy: Case report and brief review of the literature

…, PJ Serrano-Castro, E Molina-Cuadrado… - International journal of …, 2015 - Springer
Case We discuss the case of a 5-year-old long-standing epileptic woman, who received
oxcarbazepine 2.1 g/day, and levetiracetam 3 g/day (started in 2005 and up-titrated …

Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents

E Molina-Cuadrado, H Mateo-Carrrasco… - European Journal of …, 2018 - ejhp.bmj.com
Objectives Anaemia is the most common side effect associated with ribavirin (RBV). This
study intended to assess its incidence and determine its predictive factors in patients with …

Key determinants of satisfaction with residency of hospital pharmacy specialists in Spain

H Mateo-Carrasco, E Molina-Cuadrado… - Currents in Pharmacy …, 2014 - Elsevier
Background No study thus far has focused on assessing factors affecting satisfaction with
hospital pharmacy residency training. Elucidating these factors might help improve …

PP-009 Stability of intraveous injection of decitabine stored in polyethylene syringes

FD Fernández-Ginés, S Garcia-Muñoz… - 2017 - ejhp.bmj.com
Background Decitabine is indicated for the treatment of adult patients with newly diagnosed
acute myeloid leukaemia (AML) de novo or secondary, according to the classification of the …

DI-017 Mefloquine in progressive multifocal leukoencephalopathy

PN Guindo, FD Fernandez-Gines, EM Cuadrado… - 2016 - ejhp.bmj.com
Background Natalizumab increases the risk of progressive multifocal leukoencephalopathy
(PML), a potentially lethal brain disorder caused by JC polyomavirus (JCV). The antimalarial …

PS-012 Medicines reconciliation in the intensive care unit

PN Guindo, AA Martin, HM Carrasco, EM Cuadrado… - 2015 - ejhp.bmj.com
Background Medicines reconciliation is known to minimise medicines errors and reduce
morbidity in hospitalised patients. Its role in the Intensive Care Unit (ICU) has not been …

CP-023 Use of intravitreal antiangiogenic drug in a large study in the treatment of retinopathy of prematurity

…, TB Rodríguez-Cuadros, SC Paz, E Molina-Cuadrado - 2017 - ejhp.bmj.com
Background Retinopathy of prematurity (ROP) is a proliferative disease of the retinal
vasculature that can cause severe visual loss in premature newborns. Intravitreal …

DI-020 Toxic epidermal necrolysis resulting in a fatal outcome caused by use of lamotrigine

…, P Nieto-Guindo, E Molina-Cuadrado - 2017 - ejhp.bmj.com
Background Toxic epidermal necrolysis (TEN) is a rare immune mediated life threatening
reaction for which drugs account for more than 95% of cases. The incidence of TEN is 0.4 …